AstraZeneca continues hunt for RNA-based therapies

04/2/2013 | Bloomberg

AstraZeneca CEO Pascal Soriot is forging ahead with efforts to discover drugs based on RNA technology with its partnership with biotech company Moderna Therapeutics. Moderna's platform allows fast, simultaneous testing on multiple targets for messenger RNA. The company is also working on antisense therapies in partnership with Isis Pharmaceuticals.

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Attorney
Blue Cross Blue Shield of Louisiana
Baton Rouge, LA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Financial Officer
Health Alliance Plan of Michigan
Southfield, MI
Senior Vice-President Managed Care Mid-Atlantic Region
Mercy Health System
Conshohocken, PA
Associate Chief Financial Officer
Commonwealth Care Alliance
Boston, MA